Technology
Health
Medical

Conformis

$2.73
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.07 (2.80%) Today
+$0.07 (2.80%) Today

Why Robinhood?

You can buy or sell Conformis and other stocks, options, ETFs, and crypto commission-free!

About

ConforMIS, Inc. operates as a holding company, which engages in the development, manufacture and sale of joint replacement implants. Its products include iTotal, iUni and iDuo and iJig Instrumentation. Read More The company was founded by Philipp Lang in 2004 and is headquartered in Billerica, MA.

Employees
268
Headquarters
Billerica, Massachusetts
Founded
2004
Market Cap
173.67M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
564.29K
High Today
$2.87
Low Today
$2.63
Open Price
$2.75
Volume
805.92K
52 Week High
$2.95
52 Week Low
$0.358

Collections

Technology
Health
Medical
2015 IPO
US
North America

News

Simply Wall StMar 12

What Do Analysts Think About Conformis, Inc.’s (NASDAQ:CFMS) Earnings Trajectory?

In December 2018, Conformis, Inc. (NASDAQ:CFMS) released its most recent earnings announcement, which showed company earnings became less negative compared to the previous year’s level as a result of recent tailwinds Below is my commentary, albeit very simple and high-level, on how market analysts perceive Conformis’s earnings growth trajectory over the next couple of years and whether the future looks brighter. Note that I will be looking at net income excluding extraordinary items to get a better understa...

2,099
MarketBeatMar 8

Stock Price, News, & Analysis for ConforMIS

News articles about CFMS stock have trended somewhat positive on Saturday, according to InfoTrie. The research group identifies negative and positive press coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. ConforMIS earned a news impact score of 1.4 on InfoTrie's scale. They also gave media headlines about the medical instruments supplier a news buzz of 5.0 out of...

315

Earnings

-$0.36
-$0.28
-$0.20
-$0.12
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
Actual
Expected May 1, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.